Gordon Li

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 213, Stanford, CA 94305, USA
    Neurosurg Clin N Am 21:87-93. 2010
  2. pmc Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
    Gordon Li
    Department of Neurosurgery, Stanford University Medical Center, Stanford, CA 94305, USA
    J Neurooncol 108:395-402. 2012
  3. ncbi request reprint CyberKnife rhizotomy for facetogenic back pain: a pilot study
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA
    Neurosurg Focus 23:E2. 2007
  4. ncbi request reprint Irradiation of glomus jugulare tumors: a historical perspective
    Gordon Li
    Department of Neurosurgery, Stanford University Medical Center, Stanford, California 94305, USA
    Neurosurg Focus 23:E13. 2007
  5. doi request reprint Perioperative management of ventriculoperitoneal shunts during abdominal surgery
    Gordon Li
    Department of Neurosurgery, Stanford University Medical Center, Stanford, CA 94305, USA
    Surg Neurol 70:492-5; discussion 495-7. 2008
  6. doi request reprint Effects of age and comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA
    Spine (Phila Pa 1976) 33:1250-5. 2008
  7. doi request reprint Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III
    David R Emlet
    Authors Affiliations Brain Tumor Research Laboratories, Program in Cancer Biology, Stanford University Medical Center, Stanford Department of Pathology, Stanford University Medical Center, Stanford Institute of Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford Department of Neurosurgery, Stanford University School of Medicine, Stanford Veterans Affairs Palo Alto Health Care System, Palo Alto, California Department of Physiology and Pharmacology, Institute for Biomedical Research, School of Medicine, University of Salamanca, Salamanca, Spain Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts and Department of Gastroenterology, Henan Provincial People s Hospital, Zhengzhou, Henan, People s Republic of China
    Cancer Res 74:1238-49. 2014
  8. pmc Radiosurgery of glomus jugulare tumors: a meta-analysis
    Zachary D Guss
    Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Int J Radiat Oncol Biol Phys 81:e497-502. 2011
  9. doi request reprint Pineal parenchymal tumor of intermediate differentiation: clinicopathological report and analysis of epidermal growth factor receptor variant III expression
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305, USA
    Neurosurgery 66:963-8; discussion 968. 2010
  10. doi request reprint Radiosurgery for glomus jugulare: history and recent progress
    Zachary D Guss
    Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Neurosurg Focus 27:E5. 2009

Collaborators

Detail Information

Publications23

  1. doi request reprint The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 213, Stanford, CA 94305, USA
    Neurosurg Clin N Am 21:87-93. 2010
    ..In this article, the authors discuss the preclinical data that led to the human trials and the exciting preliminary data from the clinical trials...
  2. pmc Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
    Gordon Li
    Department of Neurosurgery, Stanford University Medical Center, Stanford, CA 94305, USA
    J Neurooncol 108:395-402. 2012
    ..We were therefore able to detect EGFRvIII expression in 6 of 11 DIPG cases. These data suggest that EGFRvIII warrants investigation as a target for these deadly pediatric tumors...
  3. ncbi request reprint CyberKnife rhizotomy for facetogenic back pain: a pilot study
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA
    Neurosurg Focus 23:E2. 2007
    ..The authors used CyberKnife radiosurgery to denervate affected facet joints with the goal of obtaining a less invasive yet more thorough and durable antinociceptive rhizotomy...
  4. ncbi request reprint Irradiation of glomus jugulare tumors: a historical perspective
    Gordon Li
    Department of Neurosurgery, Stanford University Medical Center, Stanford, California 94305, USA
    Neurosurg Focus 23:E13. 2007
    ..In this article the authors discuss the history of radiation therapy for glomus jugulare tumors, focusing on recent radiosurgical results...
  5. doi request reprint Perioperative management of ventriculoperitoneal shunts during abdominal surgery
    Gordon Li
    Department of Neurosurgery, Stanford University Medical Center, Stanford, CA 94305, USA
    Surg Neurol 70:492-5; discussion 495-7. 2008
    ..There is currently no established set of guidelines for this scenario. The objective of this study was to determine the risks and standard of practice for patients with VPSs undergoing abdominal surgery...
  6. doi request reprint Effects of age and comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA
    Spine (Phila Pa 1976) 33:1250-5. 2008
    ..This is a retrospective cohort study using the National Inpatient Sample database...
  7. doi request reprint Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III
    David R Emlet
    Authors Affiliations Brain Tumor Research Laboratories, Program in Cancer Biology, Stanford University Medical Center, Stanford Department of Pathology, Stanford University Medical Center, Stanford Institute of Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford Department of Neurosurgery, Stanford University School of Medicine, Stanford Veterans Affairs Palo Alto Health Care System, Palo Alto, California Department of Physiology and Pharmacology, Institute for Biomedical Research, School of Medicine, University of Salamanca, Salamanca, Spain Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Cambridge, Massachusetts and Department of Gastroenterology, Henan Provincial People s Hospital, Zhengzhou, Henan, People s Republic of China
    Cancer Res 74:1238-49. 2014
    ..This work demonstrates that a mutated oncogene can have CSC-specific expression and be used to specifically target this population...
  8. pmc Radiosurgery of glomus jugulare tumors: a meta-analysis
    Zachary D Guss
    Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA
    Int J Radiat Oncol Biol Phys 81:e497-502. 2011
    ..In the present study, we report on a systematic review and meta-analysis of the available published data on the radiosurgical management of glomus jugulare tumors...
  9. doi request reprint Pineal parenchymal tumor of intermediate differentiation: clinicopathological report and analysis of epidermal growth factor receptor variant III expression
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305, USA
    Neurosurgery 66:963-8; discussion 968. 2010
    ..Therapies targeting EGFRvIII are currently being investigated in clinical and preclinical trials...
  10. doi request reprint Radiosurgery for glomus jugulare: history and recent progress
    Zachary D Guss
    Department of Neurosurgery, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA
    Neurosurg Focus 27:E5. 2009
    ..These preliminary reports demonstrate that the use of radiosurgery as a primary treatment for glomus jugulare should be extended to encompass more of the patients who are currently assigned to microsurgical treatment...
  11. doi request reprint Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas
    Catherine A Del Vecchio
    Stanford University, 1201 Welch Road, MSLS P105, Stanford, CA 94305, USA
    Expert Rev Vaccines 11:133-44. 2012
    ..Rindopepimut therefore represents a very promising therapy for patients with GBM...
  12. doi request reprint Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma
    Wendy Hara
    Department of Radiation Oncology, Stanford University, Stanford Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305 5847, USA
    Neurosurgery 64:A26-32. 2009
    ..To evaluate the efficacy of CyberKnife (Accuray, Inc., Sunnyvale, CA) stereotactic radiosurgery (SRS) for patients with brain metastases of malignant melanoma and renal cell carcinoma...
  13. ncbi request reprint CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain
    Chirag G Patil
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California 94305 5327, USA
    Neurosurg Focus 23:E9. 2007
    ..This study represents the first report of the treatment of atypical TN with frameless CyberKnife stereotactic radiosurgery (SRS)...
  14. pmc Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
    Michelle Monje
    Department of Neurology, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 108:4453-8. 2011
    ..Together, these findings provide a foundation for understanding the cellular and molecular origins of DIPG, and suggest that the Hh pathway represents a potential therapeutic target in this devastating pediatric tumor...
  15. doi request reprint The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage
    Michael Lim
    Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Neurosurg Rev 35:413-9; discussion 419. 2012
    ..3%). Elevated serum MPO correlates with clinically evident vasospasm following aneurysmal SAH. The potential utility of MPO as a marker of vasospasm is discussed...
  16. pmc Development of an EGFRvIII specific recombinant antibody
    Puja Gupta
    Brain Tumor Research Laboratories, Department of Neurosurgery, and Program in Cancer Biology, Stanford University Medical Center, Stanford, CA 94305, USA
    BMC Biotechnol 10:72. 2010
    ..Furthermore, a monoclonal antibody to EGFRvIII is not readily available to the scientific community...
  17. doi request reprint Pathology: commonly monitored glioblastoma markers: EFGR, EGFRvIII, PTEN, and MGMT
    Joaquin Q Camara-Quintana
    Department of Neurosurgery, Stanford University, 1201 Welch Road, MSLS P309, Stanford, CA 94305, USA
    Neurosurg Clin N Am 23:237-46, viii. 2012
    ....
  18. pmc The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
    Stephen B Willingham
    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University Medical Center, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 109:6662-7. 2012
    ..CD47 is therefore a validated target for cancer therapies...
  19. doi request reprint Passive antibody-mediated immunotherapy for the treatment of malignant gliomas
    Siddhartha Mitra
    Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 200, Stanford, CA 94305, USA
    Neurosurg Clin N Am 21:67-76. 2010
    ..In this article, the authors discuss the preclinical and clinical studies that have used passive antibody-mediated immunotherapy, otherwise known as serotherapy, for the treatment of malignant gliomas...
  20. pmc Current vaccine trials in glioblastoma: a review
    Linda W Xu
    Department of Neurosurgery, Stanford University Medical Center, Stanford, CA 94304, USA
    J Immunol Res 2014:796856. 2014
    ..If the results of these randomized trials show a survival benefit, immunotherapy will become a standard part of the treatment of this devastating disease. ..
  21. doi request reprint EGF receptor variant III as a target antigen for tumor immunotherapy
    Gordon Li
    Department of Neurosurgery, Stanford University School of Medicine, 300 Pasteur Drive, Edwards Building Room 213, Stanford, CA 94305, USA
    Expert Rev Vaccines 7:977-85. 2008
    ....
  22. ncbi request reprint Intracranial hypotension from intrathecal baclofen pump insertion. A case report and review of the literature
    Shivanand P Lad
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA 94305, USA
    Stereotact Funct Neurosurg 86:75-9. 2008
    ..In this report, we present a case of intracranial hypotension secondary to baclofen pump placement. We review the major clinical findings, neuroimaging abnormalities, key diagnostic features as well as treatment options...
  23. ncbi request reprint Cerebral perfusion imaging in vasospasm
    Shivanand P Lad
    Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA
    Neurosurg Focus 21:E7. 2006
    ....